Progressive chronic kidney disease in primary care: Modifiable risk factors and predictive model

Preventive Medicine

Volumn 57, Issue 4, 2013, Pages 357-362

  Herget Rosenthal, Stefan ^a,b   Dehnen, Dorothea ^b   Kribben, Andreas ^b   Quellmann, Thomas ^b  

^a Rotes Kreuz Krankenhaus   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Chronic kidney disease; Incidence; Prediction; Prevalence; Primary care; Progression; Risk factor

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; CONTRAST MEDIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FAILURE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; PREDICTION; PREDICTOR VARIABLE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

CHRONIC KIDNEY DISEASE; INCIDENCE; PREDICTION; PREVALENCE; PRIMARY CARE; PROGRESSION; RISK FACTOR;

AGED; DIABETES COMPLICATIONS; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OBESITY; PREVALENCE; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84883795784     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2013.06.010     Document Type: Article

References (32)

1. Bagshaw S.M., Cruz D.N., Aspromonte N., et al. Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI consensus conference. Nephrol. Dial. Transplant. 2010, 25:1406-1416.
2. Bash L.D., Coresh J., Köttgen A., et al. Defining incident chronic kidney disease in the research setting: the ARIC Study. Am. J. Epidemiol. 2009, 170:414-424.
3. Bell E.K., Gao L., Judd S., et al. Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease. Am. J. Hypertens. 2012, 25:789-796.
4. Chawla L.S., Kimmel P.L. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int. 2012, 82:516-524.
5. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298:2038-2047.
6. Dehnen D., Quellmann T., Herget-Rosenthal S. Current equations estimating glomerular filtration rate in primary care: comparison and determinants. Scand. J. Urol. Nephrol. 2012, 46:448-453.
7. Dhoul N., de Lusignan S., Dmitrieva O., Stevens P., O'Donoghue D. Quality achievement and disease prevalence in primary care predicts regional variation in renal replacement therapy incidence: an ecological study. Nephrol. Dial. Transplant. 2012, 27:739-746.
8. Dickstein K., Cohen-Solal A., Filippatos G., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2008, 29:2388-2442.
9. Eckardt K.U., Barthlein B., Baid-Agrawal S., et al. The German Chronic Kidney Disease study: design and methods. Nephrol. Dial. Transplant. 2012, 27:1454-1460.
10. Ejerblad E., Fored C.M., Lindblad P., Fryzek J., McLaughlin J.K., Nyrén O. Obesity and risk for chronic renal failure. J. Am. Soc. Nephrol. 2006, 17:1695-1702.
11. Evans M., Fryzek J.P., Elinder C.G., et al. The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. Am. J. Kidney Dis. 2005, 46:863-870.
12. Evans M., Bain S.C., Hogan S., Bilous R.W. Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate. Nephrol. Dial. Transplant. 2012, 27:2255-2263.
13. Fox C.S., Larson M.G., Leip E.P., Culleton B., Wilson P.W., Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 2004, 291:844-850.
14. Gansevoort R.T., Matsushita K., van der Velde M., et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011, 80:93-104.
15. Halbesma N., Jansen D.F., Heymans M.W., Stolk R.P., de Jong P.E., Gansevoort R.T. Clin. J. Am. Soc. Nephrol. 2011, 6:1731-1738.
16. Hallan S.I., Coresh J., Astor B.C., et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J. Am. Soc. Nephrol. 2006, 17:2275-2284.
17. Hemmelgarn B.R., Manns B.J., Lloyd A., et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010, 303:423-429.
18. Herget-Rosenthal S., Quellmann T., Linden C., Hollenbeck M., Jankowski V., Kribben A. How does late nephrological co-management impact chronic kidney disease? - an observational study. Int. J. Clin. Pract. 2010, 64:1784-1792.
19. Jafar T.H., Stark P.C., Schmid C.H., et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann. Intern. Med. 2003, 139:244-252.
20. Keith D.S., Nichols G.A., Gullion C.M., Brown J.B., Smith D.H. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch. Intern. Med. 2004, 164:659-663.
21. Kshirsagar A.V., Bang H., Bomback A.S., et al. A simple algorithm to predict incident kidney disease. Arch. Intern. Med. 2008, 168:2466-2473.
22. Levey A.S., Coresh J. Chronic kidney disease. Lancet 2012, 379:165-180.
23. Levey A.S., Stevens L.A., Schmid C.H., et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009, 150:604-612.
24. Levey A.S., de Jong P.E., Coresh J., et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011, 80:17-28.
25. Mann J.F., Schmieder R.E., McQueen M., et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk: a multicentre, randomised, double-blind, controlled trial. Lancet 2008, 372:547-553.
26. Matsushita K., van der Velde M., Astor B.C., et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010, 375:2073-2081.
27. O'Seaghdha C.M., Lyass A., Massaro J.M., et al. A risk score for chronic kidney disease in the general population. Am. J. Med. 2012, 125:270-277.
28. Patel A., MacMahon S., Chalmers J., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 2008, 358:2560-2572.
29. Shastri S., Katz R., Shlipak M.G., et al. Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis. Am. J. Kidney Dis. 2011, 57:832-840.
30. Stevens P.E., O'Donoghue D.J., de Lusignan S., et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int. 2007, 72:92-99.
31. Tangri N., Stevens L.A., Griffith J., et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011, 305:1553-1559.
32. Zhang Q.L., Koenig W., Raum E., Stegmaier C., Brenner H., Rothenbacher D. Epidemiology of chronic kidney disease: results from a population of older adults in Germany. Prev. Med. 2009, 48:122-127.